sulfinpyrazone has been researched along with fibrinogen in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kinlough-Rathbone, RL; Mustard, JF; Packham, MA; Perry, DW | 1 |
Loo, J | 1 |
Hanson, SR; Harker, LA | 1 |
Ellis, J; Genton, E; Steele, P | 1 |
Ash, G; Parsons, V; Weston, MJ; Woods, HF | 1 |
Buser, P; Frick, J; Gruber, UF; Loosli, J; Matt, E; Segesser, D | 1 |
Schwartz, SI; Swedenborg, J | 1 |
Guccione, MA; Jenkins, CS; Mustard, JF; Packham, MA | 1 |
Lüscher, EF | 1 |
Evans, G; Mustard, JF | 1 |
Douglas, AS | 1 |
Didisheim, P; Fuster, V; Kazmier, FJ | 1 |
Allan, N; Bentley, NJ; Blandford, RB; Bloom, AL; Dowdle, R; Ludlam, CA | 1 |
O'Donnell, MR; Slichter, SJ; Storb, R; Weiden, PL | 1 |
Loeliger, EA | 1 |
2 review(s) available for sulfinpyrazone and fibrinogen
Article | Year |
---|---|
Management of thrombotic diseases.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Coumarins; Dextrans; Dipyridamole; Drug Antagonism; Drug Hypersensitivity; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heart Valve Prosthesis; Hemorrhage; Heparin; Histamine H1 Antagonists; Humans; Hydrocortisone; Indenes; Intracranial Embolism and Thrombosis; Iodine Isotopes; Platelet Adhesiveness; Prostaglandins; Reserpine; Rheumatic Heart Disease; Streptokinase; Sulfinpyrazone; Thrombosis | 1971 |
Platelet inhibition in the management of thrombosis.
Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamole; Fibrinogen; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Iodine Radioisotopes; Molecular Weight; Myocardial Infarction; Phlebography; Renal Dialysis; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1974 |
2 trial(s) available for sulfinpyrazone and fibrinogen
Article | Year |
---|---|
[Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
Topics: Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy; Early Ambulation; Exercise Therapy; Fibrinogen; Fibrinolysis; Heparin; Humans; Myocardial Infarction; Physical Therapy Modalities; Platelet Aggregation; Postoperative Complications; Posture; Pulmonary Embolism; Streptokinase; Sulfinpyrazone; Thromboembolism; Thrombosis | 1975 |
Effects of platelet suppressant, anticoagulant and fibrinolytic therapy in patients with recurrent venous thrombosis.
Topics: Adult; Aged; Anticoagulants; Blood Platelets; Cell Survival; Clinical Trials as Topic; Ethylestrenol; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Phenformin; Placebos; Recurrence; Sulfinpyrazone; Thrombophlebitis; Warfarin | 1978 |
11 other study(ies) available for sulfinpyrazone and fibrinogen
Article | Year |
---|---|
Factors responsible for ADP-induced release reaction of human platelets.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aspirin; Citrates; Fibrinogen; gamma-Globulins; Hemophilia A; Heparin; Hirudins; Humans; Magnesium; Phenylbutazone; Phosphates; Platelet Adhesiveness; Platelet Aggregation; Serum Albumin; Sulfinpyrazone; Thrombin | 1975 |
Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Blood Transfusion; Dipyridamole; Disease Models, Animal; Femoral Artery; Femoral Vein; Fibrinogen; Haplorhini; Heparin; Kidney; Male; Papio; Platelet Adhesiveness; Polyurethanes; Regional Blood Flow; Silicone Elastomers; Sulfinpyrazone; Thromboembolism | 1979 |
Reduction of dialyzer fibrin deposition with sulphinpyrazone.
Topics: Blood Platelets; Fibrin; Fibrinogen; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Sulfinpyrazone; Thrombocytopenia | 1979 |
Sulfinpyrazone and postoperative deep vein thrombosis.
Topics: Administration, Oral; Adult; Dextrans; Drug Evaluation; Fibrinogen; Heparin; Humans; Injections, Intravenous; Injections, Subcutaneous; Postoperative Complications; Prospective Studies; Sulfinpyrazone; Thrombophlebitis | 1977 |
Platelet adhesiveness.
Topics: Anti-Inflammatory Agents; Aspirin; Blood Platelets; Collagen; Dextrans; Endothelium; Fibrinogen; Heparin; Humans; Phenylbutazone; Platelet Adhesiveness; Sialic Acids; Sulfinpyrazone; Thromboembolism | 1975 |
Modification of platelet adherence to protein-coated surfaces.
Topics: Animals; Antimycin A; Aspirin; Caffeine; Carbon Isotopes; Cyclic AMP; Fibrinogen; gamma-Globulins; Glass; Iodine Isotopes; Iodoacetates; Phenylbutazone; Platelet Adhesiveness; Prostaglandins; Pyrimidines; Serotonin; Serum Albumin, Bovine; Sulfinpyrazone; Swine | 1973 |
Current concepts of hemostasis. Progress report on platelet aggregation.
Topics: Adenosine Diphosphate; Blood Platelets; Catecholamines; Dextrans; Fibrinogen; Hemostasis; Histamine H1 Antagonists; Humans; Phenylbutazone; Platelet Adhesiveness; Serotonin; Sulfinpyrazone | 1968 |
Platelet-surface reaction and thrombosis.
Topics: Animals; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Carbon Isotopes; Endarterectomy; Extracorporeal Circulation; Femoral Artery; Fibrinogen; gamma-Globulins; Glass; Humans; In Vitro Techniques; Polymers; Popliteal Artery; Pulse; Rabbits; Serotonin; Serum Albumin; Sulfinpyrazone; Sulfur Isotopes; Surface Properties; Thrombosis; Transplantation, Autologous; Vascular Surgical Procedures | 1968 |
Platelet and coagulation function in patients with abnormal cardiac valves treated with sulphinpyrazone.
Topics: Adult; Aged; Anticoagulants; beta-Thromboglobulin; Cell Survival; Disseminated Intravascular Coagulation; Fibrinogen; Heart Valve Prosthesis; Humans; Middle Aged; Platelet Count; Platelet Factor 4; Rheumatic Heart Disease; Sulfinpyrazone; Thromboembolism | 1981 |
Interruption of tumor-associated platelet consumption with platelet enzyme inhibitors.
Topics: Animals; Blood Platelets; Cell Survival; Cyclooxygenase Inhibitors; Dogs; Enzyme Inhibitors; Fibrinogen; Fibrinolytic Agents; Kinetics; Mopidamol; Neoplasms; Phosphodiesterase Inhibitors; Platelet Count; Sulfinpyrazone; Warfarin | 1982 |
Platelets, cardiac valves and sulphinpyrazone.
Topics: Blood Platelets; Fibrinogen; Heart Valve Diseases; Humans; Sulfinpyrazone | 1982 |